Keyphrases
COVID-19
100%
Acute Respiratory Distress Syndrome
56%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
36%
Peripheral Blood Mononuclear Cells
35%
Carbon Dioxide
34%
Sepsis
31%
Baboon
29%
Streptococcus Pneumoniae
28%
COVID-19 Patients
28%
COVID-19 Severity
24%
Lung Transplantation
23%
Acute Lung Injury
23%
Pneumonia
23%
Mitochondrial Biogenesis
21%
Severe COVID-19
20%
Central Airway Stenosis
19%
Coagulopathy
19%
Nonhuman Primate
18%
Seroconversion
17%
Hyperbaric Oxygen Therapy
17%
S. Pneumoniae
17%
Mitochondrial Quality Control
15%
Heparin
15%
Chromatin Accessibility
15%
AT2 Cells
14%
Mechanical Ventilation
14%
Mitochondrial Damage
13%
SARS-CoV-2 Infection
13%
Intensive Care Unit
13%
Bacterial Pneumonia
12%
Lung
12%
Nuclear Respiratory Factor 1 (NRF1)
12%
Invasive Mechanical Ventilation
12%
Carboxyhemoglobin (COHb)
11%
Hypoxemia
11%
Mitophagy
10%
High Mortality
10%
United States
10%
Airway
10%
Multiplexing
10%
High-flow Nasal Oxygen
10%
Airway Complications
10%
Gene Expression
10%
Odds Ratio
9%
Dysregulated
9%
Mild Symptoms
9%
Receptor-binding Domain
9%
Narrative Review
9%
Carboxyhaemoglobin Levels
9%
Hazard Ratio
9%
Medicine and Dentistry
COVID-19
89%
Extracorporeal Membrane Oxygenation
35%
Infection
34%
Acute Respiratory Distress Syndrome
33%
Lung
30%
Carbon Monoxide
28%
Hyperbaric Medicine
25%
Sepsis
25%
Pneumococcal Pneumonia
24%
Streptococcus Pneumonia
24%
Lung Transplantation
23%
Acute Lung Injury
20%
Stenosis
19%
Coagulopathy
19%
Pneumococcus
17%
Artificial Respiration
16%
Mitochondrial Biogenesis
16%
Heparin
15%
Peripheral Blood Mononuclear Cell
15%
Hypoxemia
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Disease
13%
Pathogen
11%
Epithelial Cell
11%
Sequela
10%
Biological Marker
10%
Carboxyhemoglobin
10%
Bacterial Pneumonia
10%
Granulocyte
9%
Seroconversion
9%
Respiratory Failure
9%
Gene Expression
9%
Odds Ratio
8%
Retrospective Cohort Study
8%
Ketogenic Diet
7%
Cell Population
7%
Priapism
7%
Thrombin
7%
Toll Like Receptor Agonist
7%
Blood Purification
7%
Aptamer
7%
Cohort Analysis
7%
Cardiopulmonary Bypass
7%
Bronchoconstricting Agent
7%
Acute Myeloid Leukemia
7%
Toll Like Receptor
7%
Fibrinolysis
7%
Hypercoagulability
7%
Next Generation Sequencing
7%
Innate Immunity
7%